跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RISPERDAL risperidone 4mg tablet - TGA Drug Approval Details
Approvals
/
TGA
/
RISPERDAL risperidone 4mg tablet
Approved
STANDARD
RISPERDAL risperidone 4mg tablet
Janssen-Cilag Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
6264e3c0db6c024f
Company
Janssen-Cilag Pty Ltd
Type
Standard
Approval Details
Approval Id
6264e3c0db6c024f
Product Name
RISPERDAL risperidone 4mg tablet
Artg Id
47011
Artg Name
RISPERDAL risperidone 4mg tablet blister pack
Sponsor
Janssen-Cilag Pty Ltd
Company Detail Path
/organization/janssen-cilag-pty-ltd
Artg Date
1993-11-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4f4057065d4f7525a5336d8242a50729.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/6991c0354b8d86659ff0932ae6ac397b.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
6264e3c0db6c024f
Type
Standard
Back to TGA Approvals